
Margaret Shipp
Douglas S. Miller Chair in Hodgkin Lymphoma · Mass General Brigham
Credentials: · ·
History
Research
Review · Journal of Clinical Oncology · 1999 · 3,123 citations
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
New England Journal of Medicine · 2015 · 2,937 citations
Nature Medicine · 2018 · 1,629 citations

62 papers · 4 as a fellow

31 papers
- JK
26 papers

20 papers

14 papers

14 papers

14 papers · 1 as a fellow

13 papers
Grants
- 2011–2022
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
National Cancer Institute · R01
Contact PI · $4M · Dana-Farber Cancer Inst
- 2016
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Project lead · $752.9K · Dana-Farber Cancer Inst
- 2001–2013
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
National Cancer Institute · P01
Contact PI · $32.9M · Dana-Farber Cancer Inst
- 1998–2004
Stromelysin 3 and the Tumor Microenvironment
National Cancer Institute · R01
Contact PI · $1.2M · Dana-Farber Cancer Inst



